The gross proceeds to Retension from the offering are expected to be $45.0 million, and the offering is expected to close on or about October 13, 2026. Retension intends to use the net proceeds from ...

Indian shares were notably higher in early trade on Friday after U.S. President Donald Trump ruled out attacking Iran before the U.S. midterm elections on November 3, asserting that record volumes of ...

Bic Camera Inc. (1U3.F) reported a profit for its full year that Increased, from the same period last year The company's bottom line totaled JPY20.353 billion, or JPY118.68 per share. This compares ...

The Clash have announced the release of The World According to The Clash, an 11-track compilation originally distributed to U ...

The U.S. Department of Labor has suspended Microsoft ( MSFT) and Adobe from its Permanent Labor Certification programme amid ...

A$AP Rocky has announced a four-year, full-tuition scholarship for a student attending the Roc Nation School of Music, Sports ...

Starbucks (SBX) has explored a potential takeover of Chipotle Mexican Grill, a move that could create the largest deal in ...

New York's iconic Chrysler Building is set for a $235 million renovation after developer Tishman Speyer took over the ...

Thursday, TRexBio announced the pricing of its initial public offering of 8.33 million shares at $14.00 per share, raising approximately $116.7 million in gross proceeds. The company's shares are ...

Stocks moved mostly lower during trading on Thursday, adding to the modest losses posted in the previous session. The ...

SYCUME achieved a 60.4% proptosis response rate and a mean reduction of 1.88 mm in eye protrusion at Week 24, while maintaining a favorable safety profile. The therapy is the first IGF-1R antibody ...

Phytonadione, commonly known as vitamin K1, is used to treat and prevent hypoprothrombinemia, a condition in which the blood does not clot properly, as well as vitamin K deficiency. These conditions ...